Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1977 Sep;88(3):595–618.

Rapid Emergence of Carcinogen-Induced Hyperplastic Lesions in a New Model for the Sequential Analysis of Liver Carcinogenesis

Dennis B Solt, Alan Medline, Emmanuel Farber
PMCID: PMC2032374  PMID: 18937

Abstract

Hyperplastic liver lesions which develop following administration of hepatocarcinogens have been implicated as probable precursors for the cancers which ultimately develop. Some, and possibly all, of these putative precursor lesions are resistant to the necrogenic and growth-inhibitory action of hepatocarcinogens and other hepatotoxins. An in vivo assay system based on this resistance phenomenon has been developed which encourages the rapid selective growth of carcinogen-altered hepatocytes, facilitating their early identification. The system consists of a) single carcinogenic dose of diethylnitrosamine (DEN), b) short-term dietary exposure to 2-acetylaminofluorene (2-AAF) sufficient to suppress growth of virtually all normal hepatocytes, and c) partial hepatectomy (PH) to actuate rapid growth of DEN-altered hepatocytes not suppressed by 2-AAF. Following PH, the DEN-altered hepatocytes grow out as basophilic foci which are distributed randomly throughout the 2-AAF-suppressed parenchyma. Within 1 week they can be seen as tiny, discrete, translucent nodules on the capsular and cut surface of the remaining lobes. The lesions continue to proliferate and become histologically indistinguishable from typical carcinogen-induced hyperplastic liver nodules frequently described in the literature. These in turn appear to be precursor lesions for at least some hepatocellular carcinomas. Future experimentation based on this phenomenon of “selective resistance to cytotoxicity” should prove valuable in answering specific questions about the carcinogenic process in liver and possibly in other tissues.

Full text

PDF
595

Images in this article

618Figure 9
on p.618
614Figure 4
on p.614
614Figure 5
on p.614
615Figure 6
on p.615
611Figure 1
on p.611
612Figure 2
on p.612
616Figure 7
on p.616
613Figure 3
on p.613
617Figure 8
on p.617

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becker F. F., Klein K. M. The effect of L-asparaginase on mitotic activity during N-2-fluorenylacetamide hepatocarcinogenesis: subpopulations of nodular cells. Cancer Res. 1971 Feb;31(2):169–173. [PubMed] [Google Scholar]
  2. COTE J., OEHLERT W., BUECHNER F. [Autoradiographic studies on DNA synthesis during experimental cancerization of liver parenchyma cells in rats after diethylnitrosamine]. Beitr Pathol Anat. 1962 Dec;127:450–473. [PubMed] [Google Scholar]
  3. Cameron R., Sweeney G. D., Jones K., Lee G., Farber E. A relative deficiency of cytochrome P-450 and aryl hydrocarbon [benzo(a)pyrene] hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver. Cancer Res. 1976 Nov;36(11 Pt 1):3888–3893. [PubMed] [Google Scholar]
  4. Coggin J. H., Jr, Anderson N. G. Cancer, differentiation and embryonic antigens: some central problems. Adv Cancer Res. 1974;19(0):105–165. doi: 10.1016/s0065-230x(08)60053-6. [DOI] [PubMed] [Google Scholar]
  5. Craddock V. M. Effect of a single treatment with the alkylating carcinogens dimethynitrosamine, diethylnitrosamine and methyl methanesulphonate, on liver regenerating after partial hepatectomy. I. Test for induction of liver carcinomas. Chem Biol Interact. 1975 May;10(5):313–321. doi: 10.1016/0009-2797(75)90052-6. [DOI] [PubMed] [Google Scholar]
  6. Dawson K. M. Time course of the effect of AAF on mouse liver nucleic acid synthesis and its modification by inhibitors. Chem Biol Interact. 1972 Aug;5(3):153–165. doi: 10.1016/0009-2797(72)90051-8. [DOI] [PubMed] [Google Scholar]
  7. Epstein S., Ito N., Merkow L., Farber E. Cellular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism. Cancer Res. 1967 Sep;27(9):1702–1711. [PubMed] [Google Scholar]
  8. FARBER E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene. Cancer Res. 1956 Feb;16(2):142–148. [PubMed] [Google Scholar]
  9. Farber E., Parker S., Gruenstein M. The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens. Cancer Res. 1976 Nov;36(11 Pt 1):3879–3887. [PubMed] [Google Scholar]
  10. Farber E. Putative precursor lesions: summary and some analytical considerations. Cancer Res. 1976 Jul;36(7 Pt 2):2703–2705. [PubMed] [Google Scholar]
  11. Fishman W. H. Activation of developmental genes in neoplastic transformation. Cancer Res. 1976 Sep;36(9 Pt 2):3423–3428. [PubMed] [Google Scholar]
  12. GELSTEIN V. I. SOME BIOLOGICAL CHARACTERISTICS OF LIVER CELLS IN THE COURSE OF EXPERIMENTAL CARCINOGENESIS IN MICE. Acta Unio Int Contra Cancrum. 1963;19:549–551. [PubMed] [Google Scholar]
  13. GRISHAM J. W. A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-H3. Cancer Res. 1962 Aug;22:842–849. [PubMed] [Google Scholar]
  14. GRISHAM J. W., HARTROFT W. S. Morphologic identification by electron microscopy of "oval" cells in experimental hepatic degeneration. Lab Invest. 1961 Mar-Apr;10:317–332. [PubMed] [Google Scholar]
  15. Gravela E., Feo F., Canuto R. A., Garcea R., Gabriel L. Functional and structural alterations of liver ergastoplasmic membranes during DL-ethionine hepatocarcinogenesis. Cancer Res. 1975 Nov;35(11 Pt 1):3041–3047. [PubMed] [Google Scholar]
  16. Kalengayi M. M., Ronchi G., Desmet V. J. Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1-induced carcinogenesis. J Natl Cancer Inst. 1975 Sep;55(3):579–588. doi: 10.1093/jnci/55.3.579. [DOI] [PubMed] [Google Scholar]
  17. Kitagawa T. Responsiveness of hyperplastic lesions and hepatomas to partial hepatectomy. Gan. 1971 Jun;62(3):217–224. [PubMed] [Google Scholar]
  18. LAWS J. O. Tissue regeneration and tumour development. Br J Cancer. 1959 Dec;13:669–674. doi: 10.1038/bjc.1959.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Markert C. L. Neoplasia: a disease of cell differentiation. Cancer Res. 1968 Sep;28(9):1908–1914. [PubMed] [Google Scholar]
  20. Okita K., Gruenstein M., Klaiber M., Farber E. Localization of alpha-fetoprotein by immunofluorescence in hyperplastic nodules during hepatocarcinogenesis induced by 2-acetylaminofluorene. Cancer Res. 1974 Oct;34(10):2758–2763. [PubMed] [Google Scholar]
  21. Okita K., Noda K., Fukumoto Y., Takemoto T. Cytochrome P-450 in hyperplastic liver nodules during hepatocarcinogenesis with N-2-fluorenylacetamide in rats. Gan. 1976 Dec;67(6):899–902. [PubMed] [Google Scholar]
  22. PREHN R. T. A CLONAL SELECTION THEORY OF CHEMICAL CARCINOGENESIS. J Natl Cancer Inst. 1964 Jan;32:1–17. [PubMed] [Google Scholar]
  23. Phillips M. J., Steiner J. W. Electron microscopy of cirrhotic nodule Tubularization of the parenchyma by biliary hepatocytes. Lab Invest. 1966 May;15(5):801–817. [PubMed] [Google Scholar]
  24. RUBIN E., MASUKO K., GOLDFARB S., ZAK F. G. ROLE OF CELL PROLIFERATION IN HEPATIC CARCINOGENESIS. Proc Soc Exp Biol Med. 1964 Feb;115:381–384. doi: 10.3181/00379727-115-28919. [DOI] [PubMed] [Google Scholar]
  25. Rabes H., Hartenstein R., Scholze P. Hemmung der Proliferationsaktivität partiell resezierter Leber durch Diäthylnitrosamin. Z Krebsforsch. 1970;73(3):239–241. [PubMed] [Google Scholar]
  26. Rappaport A. M. The microcirculatory hepatic unit. Microvasc Res. 1973 Sep;6(2):212–228. doi: 10.1016/0026-2862(73)90021-6. [DOI] [PubMed] [Google Scholar]
  27. Rubin E., Popper H. The evolution of human cirrhosis deduced from observations in experimental animals. Medicine (Baltimore) 1967 Mar;46(2):163–183. doi: 10.1097/00005792-196703000-00009. [DOI] [PubMed] [Google Scholar]
  28. Rutenburg A. M., Kim H., Fischbein J. W., Hanker J. S., Wasserkrug H. L., Seligman A. M. Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity. J Histochem Cytochem. 1969 Aug;17(8):517–526. doi: 10.1177/17.8.517. [DOI] [PubMed] [Google Scholar]
  29. Scherer E., Hoffmann M. Probable clonal genesis of cellular islands induced in rat liver by diethylnitrosamine. Eur J Cancer. 1971 Aug;7(4):369–371. doi: 10.1016/0014-2964(71)90083-1. [DOI] [PubMed] [Google Scholar]
  30. Solt D. B., Hay J. B., Farber E. Comparison of the blood supply to diethylnitrosamine-induced hyperplastic nodules and hepatomas and to the surrounding liver. Cancer Res. 1977 Jun;37(6):1686–1691. [PubMed] [Google Scholar]
  31. Uriel J. Cancer, retrodifferentiation, and the myth of Faust. Cancer Res. 1976 Nov;36(11 Pt 2):4269–4275. [PubMed] [Google Scholar]
  32. Weinhouse S. Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture. Cancer Res. 1972 Oct;32(10):2007–2016. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES